Lung Transplantation

The lung transplant department primarily serves patients with end-stage lung diseases, such as idiopathic pulmonary fibrosis, chronic obstructive pulmonary disease, bronchiectasis, cystic fibrosis, and pulmonary hypertension, whose conditions have progressed despite standard treatment. Core tasks include transplant assessment, waiting period management, perioperative care, rejection monitoring, and management of long-term complications. Transplantation can improve the survival and quality of life for some patients with end-stage lung disease, but strict screening of indications and assessment of infection, nutrition, psychological, and social support are essential. Major postoperative risks include primary graft dysfunction, acute and chronic rejection, opportunistic infections, airway complications, kidney damage, and metabolic abnormalities. The risks of transplantation may significantly increase in the presence of active infections, recent malignancies, severe comorbidities, or poor adherence. Long-term follow-up requires close monitoring of lung function, imaging evaluation, drug concentration monitoring, vaccination, and pulmonary rehabilitation training.